WallachBeth Capital Initiates Research Coverage of AzurRx

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
WallachBeth Capital Initiates Research Coverage of AzurRx BioPharma

BROOKLYN, N.Y., Dec. 12, 2016 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, announced today that WallachBeth Capital, an investment bank focused on smallcap and microcap public companies, has initiated coverage on AzurRx. For more information on the coverage report, click here , and please contact WallachBeth Capital.

The investment opinions expressed in the report are solely those of WallachBeth Capital.

About AzurRx BioPharma, Inc.:

AzurRx BioPharma, Inc. (NASDAQ: AZRX ) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company's lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. Additional information on the company can be found at  www.azurrx.com .

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of the Private Securities Litigations Reform Act of 1995. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to the development and testing of our drug candidates, the regulatory approval process, our ability to secure additional financing, the protection of our patent and intellectual property, the success of strategic agreements and relationships, and the potential commercialization of any product we may successfully develop.  We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more Information: AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 217 Brooklyn, NY 11226 Phone: 646.699.7855 www.azurrx.com info@azurrx.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Updated Category News Views 72

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 157

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading
Betterness Expands Health Networks with $3.5M Boost

Updated Category News Views 55

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 124

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
AI-Driven Software Growth Faces Profitability Hurdles

Updated Category News Views 115

AI and Growth: A Tale of Two Strategies Is AI the superhero we’ve been waiting for, or just another fad? The KeyBanc Capital Markets' 2026 AI x Software Benchmark throws more questions into the ring than it answers. This benchmark isn't just numbers on a page; it's a pulse check on how AI is reshaping the software landscape. Seeing AI-native firms grow at a dizzying 34%...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 72

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Maritime Launch's Bold Q3 Surge Amid Space Race

Updated Category News Views 193

Rockets, Revenue, and a Bold New Path You ever hear about a spaceport tucked away in the toes of Nova Scotia, making waves with its third-quarter earnings? Well, that's exactly what's cooking over at Maritime Launch Services. These folks have managed to turn a zero into hero in a flash, reporting $5.6 million in revenue and a snug $3.5 million in net income for Q3 2026....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 162

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Where Winds Meet Celebrates 1st Anniversary With New Region

Updated Category News Views 92

A Staggering Universe Deepens: Hutuo's Introduction Just when you think you've seen it all, NetEase Games and Everstone Studio go and launch Hutuo, a compelling addition to the already sprawling universe of Where Winds Meet. On the occasion of its first global anniversary, this epic Wuxia ARPG throws players into the mud-soaked, steel-clashing chaos of a warzone, testing...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 134

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading

Top 5 Most Recently Viewed Articles

Kichler and Progress Lighting Launch Unified Exhibit at KBIS 2026

Updated Category News Views 140

Unified Lighting Design Experience at KBIS 2026 Join Kichler and Progress Lighting as they unveil a fresh and innovative lighting showcase at KBIS 2026. The collaborative effort of these two leading brands marks a significant milestone in their ongoing commitment to revolutionizing modern living spaces through exceptional design. For the very first time, they will jointly...

Continue Reading
Blend Labs to Announce Year-End Financial Results Soon

Updated Category News Views 255

Blend Labs Announces Upcoming Financial Results Blend Labs, Inc. (NYSE: BLND), recognized as a leader in digital banking solutions, is preparing to release its financial results for the fourth quarter and full year of 2024. This announcement comes as the company continues to excel in providing innovative banking technologies to various financial institutions. Schedule for...

Continue Reading
Psilera Inc. Receives NIH Grant for Innovative Alcohol Treatment

Updated Category News Views 132

Psilera Inc. Advances Alcohol Use Disorder Research Psilera Inc. is making significant strides in the field of neuroplasticity as it embarks on a groundbreaking study focused on treating Alcohol Use Disorder (AUD). This endeavor is backed by a notable Small Business Innovation Research Grant, which aims to propel the development of a novel neuroplastogen toward...

Continue Reading
Fazoli’s Unveils Exciting New Lasagna Roll Options for Fans

Updated Category News Views 287

Fazoli’s Innovates with New Lasagna Roll Offerings Fazoli’s, America’s favorite fast and fresh Italian restaurant chain, is kicking off the new year with an exciting culinary twist. The restaurant is thrilled to introduce its all-new Lasagna Rolls, available for a limited time. This fresh take on a classic dish is set to delight pasta enthusiasts looking for...

Continue Reading
Leadership Transitions at NBHWC: A New Era for Coaching

Updated Category News Views 135

Leadership Transitions at NBHWC The National Board for Health and Wellness Coaching (NBHWC) has announced significant leadership changes that position the organization toward a future focused on enhancing health and wellness coaching. This move underscores a commitment to advancing the profession through evidence-based educational standards and increased accessibility for...

Continue Reading